John Kim, M.D. - Chicago Plastic Surgeon
John Y.S. Kim, MD, is a Board-Certified Plastic Surgeon and Attending Surgeon at Northwestern Memorial Hospital and Prentice Women’s Hospital.
He is a magna cum laude graduate of Harvard University, and received his Doctor of Medicine and Master of Arts in English degrees from Stanford University.
Dr. Kim is the Clinical Director of the Northwestern University Feinberg School of Medicine’s Division of Plastic Surgery and is a nationally recognized leader in innovations in breast cancer reconstruction.
Dr. Kim holds several patents on a unique class of medical devices and sits on the Editorial Board for the Annals of Plastic Surgery. Dr. Kim’s work has been featured in national media outlets, including ABC News, the Chicago Sun-Times, and eMedicine.com. He has given over 100 lectures and Grand Rounds presentations on new techniques in plastic surgery. Dr Kim has published over 50 articles and chapters in the plastic surgery literature.
In clinical practice, Dr. Kim performs the full spectrum of plastic surgery, including:
- Cosmetic and reconstructive breast surgery
- Body contouring (tummy tucks, liposuction, arm and thigh lifts)
- Facial plastic surgery, including office-based procedures
- Botox and filler injectables
- Specialized microsurgery
- Post-cancer reconstruction
- Hand and peripheral nerve surgery
For a consultation with Dr. Kim, please contact:
Melissa Eckl
312.695.3615
The FDA has issued a communication regarding a possible link between a rare form of lymphoma and breast implants. Anaplastic large cell lymphoma (ALCL) of the breast is diagnosed in women at an incidence of 3 per 100 million per year. There have been few reported cases: approximately 60 ALCL patients have had breast implants (of the estimated 5-10 million women with breast implants worldwide).
Currently the FDA is not recommending any change in the treatment of patients who have implants. Standard physical examinations and routine mammogram or MRI recommendations should be adhered to. There may be a clinical association of ALCL in select patients with late onset, persistent implant seromas and these patients should be evaluated with possible biopsy of the fluid and tissue.
The Division of Plastic and Reconstructive Surgery at Northwestern is closely monitoring the information being released by the FDA and the governing American Society of Plastic Surgeons. We will provide updates through our website: www.northwesternplasticsurgery.com
A link to the FDA news release is provided here